ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD
Holding ACAD?
Track your performance easily

ACADIA Pharmaceuticals (ACAD) Financial Statements

2,253 Followers

ACADIA Pharmaceuticals Financial Overview

ACADIA Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $0.772; its P/E ratio is 22.86; ACADIA Pharmaceuticals is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $0.23. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 250.40M$ 241.96M$ 205.83M$ 231.04M$ 211.70M
Gross Profit$ 231.54M$ 223.73M$ 182.88M$ 213.15M$ 197.08M
EBIT$ 38.77M$ 37.19M$ 21.00M$ 34.94M$ -57.78M
EBITDA$ 41.34M$ 41.55M$ 24.74M$ 36.58M$ -56.05M
Net Income Common Stockholders$ 32.77M$ 33.38M$ 16.55M$ 45.77M$ -65.18M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 626.37M$ 572.47M$ 532.46M$ 474.68M$ 366.69M
Total Assets$ 976.87M$ 914.10M$ 855.10M$ 748.96M$ 632.54M
Total Debt$ 40.42M$ 47.19M$ 49.19M$ 47.80M$ 48.10M
Net Debt$ -585.95M$ -525.28M$ -483.27M$ -426.88M$ -318.58M
Total Liabilities$ 399.69M$ 397.40M$ 391.06M$ 317.20M$ 270.37M
Stockholders Equity$ 577.18M$ 516.70M$ 464.04M$ 431.75M$ 362.17M
Cash Flow-
Free Cash Flow$ 63.18M$ 25.01M$ 29.08M$ 85.39M$ -59.01M
Operating Cash Flow$ 63.25M$ 25.01M$ 29.08M$ 85.39M$ -58.95M
Investing Cash Flow$ -82.46M$ -56.19M$ -14.04M$ -347.00K$ 34.11M
Financing Cash Flow$ 268.00K$ 3.56M$ 1.04M$ 5.43M$ 12.75M
Currency in USD

ACADIA Pharmaceuticals Earnings and Revenue History

ACADIA Pharmaceuticals Debt to Assets

ACADIA Pharmaceuticals Cash Flow

ACADIA Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis